ArticleBiomarker research2025

Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients.

Tzu-Chun Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.